| Unique ID issued by UMIN | UMIN000059050 |
|---|---|
| Receipt number | R000067539 |
| Scientific Title | Research on the functional and safety assessment of test food intake : Open-label study |
| Date of disclosure of the study information | 2025/09/17 |
| Last modified on | 2025/09/10 12:53:28 |
Research on the functional and safety assessment of test food intake
Research on the functional and safety assessment of test food intake
Research on the functional and safety assessment of test food intake
: Open-label study
Research on the functional and safety assessment of test food intake
: Open-label study
| Japan |
Healthy elementary school student
| Child |
Others
NO
Evaluation of the effects and safety on immune function by continuously ingestion of test food for 8 weeks.
Safety,Efficacy
Diary
Medical examination
s-IgA in saliva
Height measurement
Blood pressure
Inbody (weight, muscle mass)
Brief-type Diet History Questionnaire for 15-year-old
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
| Food |
Intake of test food for 8 consecutive weeks
| 6 | years-old | <= |
| 12 | years-old | >= |
Male and Female
(1) Healthy elementary school students (1st to 6th grades: excluding menstrual periods)
(2) Subjects whose parents or legal guardians (hereinafter referred to as 'guardians') received a full explanation of the purpose and content of the study, fully understood it, and voluntarily provided written informed consent for the subject's participation in the study
(1) Subjects with a history of mental illness, diabetes, liver diseases, renal disease, gastrointestinal disease, cardiac disease, respiratory disease, peripheral vascular disease, or other serious disease.
(2) Subjects who have undergone gastrointestinal surgery.
(3) Subjects showing abnormal liver and kidney function test values.
(4) Subjects with a current medical condition. (excluding cavity treatment)
(5) Subjects who are allergic to food and drugs.
(6) Subjects who participate in strenuous sports and subjects who are trying to lose weight.
(7) Subjects with extremely irregular eating habits.
(8) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the study period.
(9) Subjects who are continuously treated with medications (including OTC, prescription drugs).
(10) Subjects who are currently participating in other clinical studies or are scheduled to participate in research at the start of this study.
(11) Other subjects judged by the investigator or the investigator to be inappropriate for the examination.
20
| 1st name | Yumi |
| Middle name | |
| Last name | Takeda |
Kewpie Corporation
R&D Division
1820002
2-5-7 Sengawacho, Chofu-shi, Tokyo
03-5384-7759
yumi_takeda@kewpie.co.jp
| 1st name | Makoto |
| Middle name | |
| Last name | Terashima |
Oneness Support Co., Ltd.
Clinical Trial Division
5300044
Higashitenma building 6F, 1-7-17, Higashitenma, Kita-ku, Osaka
06-4801-8917
mterashima@oneness-sup.co.jp
Miura Clinic, Medical Corporation Kanonkai
Kewpie Corporation
Profit organization
The Ethics Committe of Miura Clinic, Medical Corporation Kanonkai
Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka
06-6135-5200
mterashima@miura-cl.jp
NO
医療法人花音会みうらクリニック(大阪府)
| 2025 | Year | 09 | Month | 17 | Day |
Unpublished
Preinitiation
| 2025 | Year | 08 | Month | 28 | Day |
| 2025 | Year | 08 | Month | 28 | Day |
| 2025 | Year | 09 | Month | 18 | Day |
| 2025 | Year | 12 | Month | 31 | Day |
| 2025 | Year | 09 | Month | 10 | Day |
| 2025 | Year | 09 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000067539